Skip Page Header

Home > What should be done about mephedrone?

The Editor. (2010) What should be done about mephedrone? BMJ, 340, p. 1605. https://doi.org/10.1136/bmj.c1605.

External website: http://www.bmj.com/cgi/content/full/340/mar23_1/c1...

The recent deaths of two young men who are thought to have taken the β keto-amphetamine stimulant mephedrone (4-methylmethcathinone) have prompted urgent calls for the drug to be banned. As we write, there is no certainty that mephedrone caused these two deaths, but it may be implicated. Amphetamine-type stimulants are known to cause about 100, mostly accidental, deaths a year in the United Kingdom.


Item Type
Article
Publication Type
International, Open Access, Article
Drug Type
CNS stimulants, New psychoactive substance
Date
23 March 2010
Identification #
https://doi.org/10.1136/bmj.c1605
Page Range
p. 1605
Corporate Creators
The Editor
Volume
340
Notes
[Editorial]
EndNote
Accession Number
HRB (Available)

Repository Staff Only: item control page